Treatment resistant depression, suicidal thoughts and behavior
If you have suffered from depression and tried two or more antidepressants in your current episode without adequate relief, you might suffer from treatment-resistant depression.
SPRAVATO® (esketamine) is the first nasal spray medication approved by the Food and Drug Administration, taken along with an oral antidepressant, for adults with treatment-resistant depression, and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior.
My office is a certified SPRAVATO® treatment center and I am very excited to provide this new service to my patients. Please call my office for more information about this effective new medication for treatment-resistant depression and suicidal thoughts and behavior.
Also, more information is available at www.spravato.com